
Verras offers patented data analytics solutions for healthcare, uniquely addressing Medicare recipients' needs in the US.
Founded to revolutionize healthcare data analytics, Verras focuses on providing transparent and patented analytic solutions tailored for the healthcare industry. Their core mission is to harness data intelligently to enhance healthcare services and value. Verras offers several proprietary tools, including the Acuity Index Method™ (AIM), Verras Sherlock™, Verras Watson™, Medical Value Index™ (MVI), and Physician Scorecard™, which are designed to measure resource consumption and clinical variation. Their market focus is primarily on payers, physicians, and hospitals in the United States, particularly addressing the needs of Medicare recipients.
Notable figures affiliated with Verras include its leadership team, comprised of experts in healthcare analytics and data science. The company has attracted significant interest from investors who recognize the potential of their patented solutions to transform healthcare delivery. Key achievements include the successful implementation of their tools in various healthcare settings, leading to improved efficiency and patient outcomes. Overall, Verras has made a substantial impact by enabling healthcare providers to make data-driven decisions that enhance care quality and operational efficiency.
Companies similar to Verras include VisiQuate, Verato, Versium and Medicare Pathfinder.
Verras was founded in 2021.
Verras' headquarters is located in Las Vegas, NV, US.
Verras' most recent funding round was for $250k (USD) in October 2021.
As of Oct 1, 2021, Verras has disclosed funding of $250k (USD). Undisclosed round amounts are excluded.
Verras has 4 employees as of Feb 4, 2024.
Medicare Pathfinder